Nanotechnology in Medical Devices Market Size By Product, By Indication, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022

Description

List of Tables

The nanotechnology in medical devices market is primed to amass substantial gains by 2030 owing to significant product penetration in disease treatment and prevention. In addition, prominent government initiatives undertaken to incorporate nanotechnology in the healthcare sector, along with the expanding geriatric population, are likely to further propel market growth over the forecast period.

During the COVID-19 pandemic, the industry witnessed a negative impact due to limitations on accessibility to a wide range of healthcare services, hampering customer reach. However, in the post-pandemic scenario, increased government support and mounting emphasis on R&D programs have elevated the demand for nanotechnology.

Additionally, soaring awareness pertaining to the potential uses of nanotechnology in varied industries, including tissue engineering and microelectronics, among others, has been lucrative for the product landscape. For instance, in 2022, the Engineering and Physical Sciences Research Council under the UK government invested £29 million (around $33 million) in graphene and carbon nanotechnology research through university grants. The initiative is aimed at expanding the scope of application of nanotechnology in the healthcare sector.

Furthermore, key players in the nanotechnology in medical devices market have been engaging in strategic collaborations and partnerships, along with extensive research initiatives to strengthen their market position and expand their customer base, fueling market progress.

To cite an instance, in March 2022, Starkey and Special Olympics, the international non-profit organization, signed a global partnership agreement to enhance access to hearing health services worldwide for individuals with intellectual disabilities. This agreement was intended to help the company expand its product portfolio by incorporating the latest technologies comprising nanotechnology in its products.

The nanotechnology in medical devices market has been bifurcated in terms of product, end-use, indication, and region.

Based on product, the market has been divided into implantable medical devices, wound care, dental filling material, and others. The dental filling material segment is slated to capture a prominent revenue share by 2030 due to the high strength of nanomaterials used in dental fillings. The materials enhance the dentin & biomaterial bond, making them more effective than conventional materials.

With respect to indication, the nanotechnology in medical devices industry has been classified into hearing loss, dentistry, orthopedics, wound care, and others. The wound care segment is poised to showcase appreciable growth over 2022-2030 due to the low toxicity and antibacterial activity of wound care nanoparticles, such as silver, gold, and zinc, which is projected to encourage consumers to opt for nanotech wound care.

In the regional context, the Europe nanotechnology in medical devices market is speculated to account for a notable industry share by 2030 as a result of surging demand for minimally invasive surgeries and time- & cost-effective medical procedures in the region.

Product Code: 3784

Chapter 1 Methodology & Scope

1.1 Market definitions
1.2 Base estimates and working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
- 1.5.1 Secondary
  - 1.5.1.1 Paid sources
  - 1.5.1.2 Unpaid sources
- 1.5.2 Primary

Chapter 2 Executive Summary

2.1 Nanotechnology in medical devices industry 360 degree synopsis, 2017 - 2030 (USD Million)
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Indication trends
- 2.1.4 End-use trends
- 2.1.5 Regional trends

Chapter 3 Nanotechnology in Medical Devices Industry Insights

3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030 (USD Million)
3.3 Industry impact factors
- 3.3.1 Growth drivers
  - 3.3.1.1 Rising adoption of nanotechnology in medical devices
  - 3.3.1.2 Potential to increase quality of care delivery
  - 3.3.1.3 Application of nanotechnology in disease treatment and prevention
  - 3.3.1.4 Favourable government initiatives
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 High cost of nanodevices
3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By indication
- 3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Future market trends
3.7 Technology landscape
3.8 Gap analysis
3.9 Regulatory landscape
- 3.9.1 U.S.
- 3.9.2 Europe
3.10 Porter's analysis
3.11 Competitive landscape, 2021
- 3.11.1 Company matrix analysis, 2021
3.12 PESTEL analysis

Chapter 4 Nanotechnology in Medical Devices Market, By Product

4.1 Key segment trends
4.2 Implantable medical devices
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.2 Orthopedic devices
  - 4.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.3 Hearing aids
  - 4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.4 Dental implants
  - 4.2.4.1 Market size, by region, 2017 - 2030 (USD Million)
4.3 Dental filling material
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.4 Wound care
- 4.4.1 Market size, by region, 2017 - 2030 (USD Million)
4.5 Others
- 4.5.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Nanotechnology in Medical Devices Market, By Indication

5.1 Key segment trends
5.2 Dentistry
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
5.3 Orthopedics
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
5.4 Hearing Loss
- 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
5.5 Wound Care
- 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
5.6 Others
- 5.6.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Nanotechnology in Medical Devices Market, By End-use

6.1 Key segment trends
6.2 Hospitals
- 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
6.3 Clinics
- 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
6.4 Others
- 6.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 7 Nanotechnology in Medical Devices Market, By Region

7.1 Key regional trends
7.2 North America
- 7.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.2.2 Market size, by product, 2017 - 2030 (USD Million)
  - 7.2.2.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
- 7.2.3 Market size, by indication, 2017 - 2030 (USD Million)
- 7.2.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.2.5 U.S.
  - 7.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.2.5.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.2.5.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.2.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.2.6 Canada
  - 7.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.2.6.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.2.6.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.2.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.3 Europe
- 7.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.3.2 Market size, by product, 2017 - 2030 (USD Million)
  - 7.3.2.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
- 7.3.3 Market size, by indication, 2017 - 2030 (USD Million)
- 7.3.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.5 Germany
  - 7.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.3.5.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.3.5.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.3.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.6 UK
  - 7.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.3.6.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.3.6.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.3.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.7 France
  - 7.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.3.7.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.3.7.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.3.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.8 Spain
  - 7.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.3.8.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.3.8.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.3.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.9 Italy
  - 7.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.3.9.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.3.9.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.3.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.4 Asia Pacific
- 7.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.4.2 Market size, by product, 2017 - 2030 (USD Million)
  - 7.4.2.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
- 7.4.3 Market size, by indication, 2017 - 2030 (USD Million)
- 7.4.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.5 China
  - 7.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.4.5.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.4.5.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.4.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.6 Japan
  - 7.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.4.6.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.4.6.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.4.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.7 India
  - 7.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.4.7.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.4.7.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.4.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.8 Australia
  - 7.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.4.8.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.4.8.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.4.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.9 South Korea
  - 7.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.4.9.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.4.9.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.4.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.5 Latin America
- 7.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.5.2 Market size, by product, 2017 - 2030 (USD Million)
  - 7.5.2.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
- 7.5.3 Market size, by indication, 2017 - 2030 (USD Million)
- 7.5.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.5 Brazil
  - 7.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.5.5.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.5.5.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.5.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.6 Mexico
  - 7.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.5.6.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.5.6.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.5.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.7 Argentina
  - 7.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.5.7.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.5.7.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.5.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.6 Middle East and Africa
- 7.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.6.2 Market size, by product, 2017 - 2030 (USD Million)
  - 7.6.2.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
- 7.6.3 Market size, by indication, 2017 - 2030 (USD Million)
- 7.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.5 South Africa
  - 7.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.6.5.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.6.5.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.6.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.6 Saudi Arabia
  - 7.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.6.6.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.6.6.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.6.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.7 Israel
  - 7.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
    - 7.6.7.1.1 Market size, by implantable medical devices, 2017 - 2030 (USD Million)
  - 7.6.7.2 Market size, by indication, 2017 - 2030 (USD Million)
  - 7.6.7.3 Market size, by end-use, 2017 - 2030 (USD Million)

Chapter 8 Company Profiles

8.1 Competitive dashboard, 2021
8.2 Smith & Nephew PLC
- 8.2.1 Business overview
- 8.2.2 Financial data
- 8.2.3 Product landscape
- 8.2.4 Strategic outlook
- 8.2.5 SWOT analysis
8.3 Starkey
- 8.3.1 Business overview
- 8.3.2 Financial data
- 8.3.3 Product landscape
- 8.3.4 Strategic outlook
- 8.3.5 SWOT analysis
8.4 Abbott
- 8.4.1 Business overview
- 8.4.2 Financial data
- 8.4.3 Product landscape
- 8.4.4 Strategic outlook
- 8.4.5 SWOT analysis
8.5 Straumann
- 8.5.1 Business overview
- 8.5.2 Financial data
- 8.5.3 Product landscape
- 8.5.4 Strategic outlook
- 8.5.5 SWOT analysis
8.6 Audina Hearing Instruments
- 8.6.1 Business overview
- 8.6.2 Financial data
- 8.6.3 Product landscape
- 8.6.4 Strategic outlook
- 8.6.5 SWOT analysis
8.7 Interton
- 8.7.1 Business overview
- 8.7.2 Financial data
- 8.7.3 Product landscape
- 8.7.4 Strategic outlook
- 8.7.5 SWOT analysis
8.8 Sebotek Hearing Systems
- 8.8.1 Business overview
- 8.8.2 Financial data
- 8.8.3 Product landscape
- 8.8.4 Strategic outlook
- 8.8.5 SWOT analysis
8.9 Coltene Whaledent
- 8.9.1 Business overview
- 8.9.2 Financial data
- 8.9.3 Product landscape
- 8.9.4 Strategic outlook
- 8.9.5 SWOT analysis
8.10 Shofu Dental
- 8.10.1 Business overview
- 8.10.2 Financial data
- 8.10.3 Product landscape
- 8.10.4 Strategic outlook
- 8.10.5 SWOT analysis
8.11 Medtronic
- 8.11.1 Business overview
- 8.11.2 Financial data
- 8.11.3 Product landscape
- 8.11.4 Strategic outlook
- 8.11.5 SWOT analysis
8.12 3M company
- 8.12.1 Business overview
- 8.12.2 Financial data
- 8.12.3 Product landscape
- 8.12.4 Strategic outlook
- 8.12.5 SWOT analysis
8.13 Convatec Group
- 8.13.1 Business overview
- 8.13.2 Financial data
- 8.13.3 Product landscape
- 8.13.4 Strategic outlook
- 8.13.5 SWOT analysis
8.14 Zimmer Biomet
- 8.14.1 Business overview
- 8.14.2 Financial data
- 8.14.3 Product landscape
- 8.14.4 Strategic outlook
- 8.14.5 SWOT analysis
8.15 3-D Matrix Medical Technology
- 8.15.1 Business overview
- 8.15.2 Financial data
- 8.15.3 Product landscape
- 8.15.4 Strategic outlook
- 8.15.5 SWOT analysis
8.16 Dentsply Sirona
- 8.16.1 Business overview
- 8.16.2 Financial data
- 8.16.3 Product landscape
- 8.16.4 Strategic outlook
- 8.16.5 SWOT analysis
8.17 Stryker Corporation
- 8.17.1 Business overview
- 8.17.2 Financial data
- 8.17.3 Product landscape
- 8.17.4 Strategic outlook
- 8.17.5 SWOT analysis